Banner Part of Global Study That Shows Higher Alzheimer’s Prevalence Than Expected.
Research that shows blood test analysis with more than 1 in 10 adults over 70 may be eligible for treatments to slow cognitive decline SUN CITY, Ariz. (Dec. 17, 2025) – New research has provided the first ever population-based data on the frequency of Alzheimer’s disease neuropathological changes (ADNC) – a key causal factor behind the development of dementia – and found that it […]
